Quantifying sources of uncertainty in drug discovery predictions with probabilistic models
Artificial Intelligence in the Life Sciences, ISSN: 2667-3185, Vol: 1, Page: 100004
2021
- 9Citations
- 35Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Knowing the uncertainty in a prediction is critical when making expensive investment decisions and when patient safety is paramount, but machine learning (ML) models in drug discovery typically only provide a single best estimate and ignore all sources of uncertainty. Predictions from these models may therefore be over-confident, which can put patients at risk and waste resources when compounds that are destined to fail are further developed. Probabilistic predictive models (PPMs) can incorporate all sources of uncertainty and they return a distribution of predicted values that represents the uncertainty in the prediction. We describe seven sources of uncertainty in PPMs: data, distribution function, mean function, variance function, link function(s), parameters, and hyperparameters. We use toxicity prediction as a running example, but the same principles apply for all prediction models. The consequences of ignoring uncertainty and how PPMs account for uncertainty are also described. We aim to make the discussion accessible to a broad non-mathematical audience. Equations are provided to make ideas concrete for mathematical readers (but can be skipped without loss of understanding) and code is available for computational researchers ( https://github.com/stanlazic/ML_uncertainty_quantification ).
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2667318521000040; http://dx.doi.org/10.1016/j.ailsci.2021.100004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85123096451&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2667318521000040; https://dx.doi.org/10.1016/j.ailsci.2021.100004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know